HOW CAN IMPACT500
GROW YOUR BUSINESS

  • Create strategic relaunch of your cost-effective brand.

  • Association with national prescribing safety optimisation programme.

  • Presenting the optimisation project to every CCG and their GP Practices.

  • Your cost-effective brand will benefit from significant growth within 6 months.

  • enhance the green credentials of your organisation

EXAMPLES OF PRODUCTS
WE ARE WORKING WITH

Our current product portfolio already has the capacity to generate £300 million savings for the NHS and we are sure that adding your cost-effective brands to this project will further contribute to the £1.2 billion of savings that we have identified.

References from companies that have signed up can be provided on request. 

STEROID / LABA

We started working with and analysing the cost-effectiveness of a new combination inhaler in 2014. Since then the product is now the leading combination MDI in the market and commands the third highest monthly revenue of all drugs within the NHS.*

 
 
 

Insulin Needles

Our clients cost-effective insulin needles are now the market leaders commanding 30% of the Diabetes NHS England market. We have worked together with the same partner to gain the 2nd largest market share of glucose testing strips.

 
 
 

Oxycodone MR Tablets

Following the patent expiry of Oxycontin we provided analytical insight for a new cost-effective brand. This allows identification and utilisation within the NHS to generate savings of 50% compared to the original brand. Total sales for the combined originator and new brand actually increased such was the success of the project.